Feldman Heidi M, Buysse Christina A, Hubner Lauren M, Huffman Lynne C, Loe Irene M
Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA.
J Dev Behav Pediatr. 2015 Apr;36(3):207-17. doi: 10.1097/DBP.0000000000000151.
The Patient Protection and Affordable Care Act (ACA) was designed to (1) decrease the number of uninsured Americans, (2) make health insurance and health care affordable, and (3) improve health outcomes and performance of the health care system. During the design of ACA, children in general and children and youth with special health care needs and disabilities (CYSHCN) were not a priority because before ACA, a higher proportion of children than adults had insurance coverage through private family plans, Medicaid, or the State Children's Health Insurance Programs (CHIP). ACA benefits CYSHCN through provisions designed to make health insurance coverage universal and continuous, affordable, and adequate. Among the limitations of ACA for CYSHCN are the exemption of plans that had been in existence before ACA, lack of national standards for insurance benefits, possible elimination or reductions in funding for CHIP, and limited experience with new delivery models for improving care while reducing costs. Advocacy efforts on behalf of CYSHCN must track implementation of ACA at the federal and the state levels. Systems and payment reforms must emphasize access and quality improvements for CYSHCN over cost savings. Developmental-behavioral pediatrics must be represented at the policy level and in the design of new delivery models to assure high quality and cost-effective care for CYSHCN.
《患者保护与平价医疗法案》(ACA)旨在:(1)减少未参保美国公民的数量;(2)使医疗保险和医疗保健费用可承受;(3)改善医疗保健系统的健康结果和绩效。在ACA的设计过程中,一般儿童以及有特殊医疗需求和残疾的儿童及青少年(CYSHCN)并非优先考虑对象,因为在ACA出台之前,通过私人家庭保险计划、医疗补助或州儿童健康保险计划(CHIP)获得保险覆盖的儿童比例高于成年人。ACA通过旨在使医疗保险覆盖范围普及且持续、费用可承受且充足的条款,使CYSHCN受益。ACA对CYSHCN而言存在一些局限性,包括ACA之前已存在的保险计划可获豁免、缺乏保险福利的国家标准、CHIP的资金可能被削减或取消,以及在降低成本的同时改善医疗服务的新交付模式经验有限。代表CYSHCN的宣传工作必须跟踪联邦和州层面ACA的实施情况。系统和支付改革必须强调CYSHCN的可及性和质量改善,而非成本节约。发育行为儿科学必须在政策层面以及新交付模式的设计中有所体现,以确保为CYSHCN提供高质量且具成本效益的医疗服务。